559 related articles for article (PubMed ID: 32426078)
1. Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1.
Ishida T; Nakao S; Ueyama T; Harada Y; Kawamura T
Inflamm Regen; 2020; 40():8. PubMed ID: 32426078
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of the Metabolic Shift during Somatic Cell Reprogramming.
Nishimura K; Fukuda A; Hisatake K
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067778
[TBL] [Abstract][Full Text] [Related]
3. Current understanding and future perspectives of the roles of sirtuins in the reprogramming and differentiation of pluripotent stem cells.
Hsu YC; Wu YT; Tsai CL; Wei YH
Exp Biol Med (Maywood); 2018 Mar; 243(6):563-575. PubMed ID: 29557214
[TBL] [Abstract][Full Text] [Related]
4. HIF1α modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1-3 and PKM2.
Prigione A; Rohwer N; Hoffmann S; Mlody B; Drews K; Bukowiecki R; Blümlein K; Wanker EE; Ralser M; Cramer T; Adjaye J
Stem Cells; 2014 Feb; 32(2):364-76. PubMed ID: 24123565
[TBL] [Abstract][Full Text] [Related]
5. A Role for KLF4 in Promoting the Metabolic Shift via TCL1 during Induced Pluripotent Stem Cell Generation.
Nishimura K; Aizawa S; Nugroho FL; Shiomitsu E; Tran YTH; Bui PL; Borisova E; Sakuragi Y; Takada H; Kurisaki A; Hayashi Y; Fukuda A; Nakanishi M; Hisatake K
Stem Cell Reports; 2017 Mar; 8(3):787-801. PubMed ID: 28262547
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial resetting and metabolic reprogramming in induced pluripotent stem cells and mitochondrial disease modeling.
Hsu YC; Chen CT; Wei YH
Biochim Biophys Acta; 2016 Apr; 1860(4):686-93. PubMed ID: 26779594
[TBL] [Abstract][Full Text] [Related]
7. Patient-derived induced pluripotent stem cells for models of cancer and cancer stem cell research.
Chao HM; Chern E
J Formos Med Assoc; 2018 Dec; 117(12):1046-1057. PubMed ID: 30172452
[TBL] [Abstract][Full Text] [Related]
8. NRF2 Orchestrates the Metabolic Shift during Induced Pluripotent Stem Cell Reprogramming.
Hawkins KE; Joy S; Delhove JM; Kotiadis VN; Fernandez E; Fitzpatrick LM; Whiteford JR; King PJ; Bolanos JP; Duchen MR; Waddington SN; McKay TR
Cell Rep; 2016 Mar; 14(8):1883-91. PubMed ID: 26904936
[TBL] [Abstract][Full Text] [Related]
9. Metabolic control of induced pluripotency.
Sinenko SA; Tomilin AN
Front Cell Dev Biol; 2023; 11():1328522. PubMed ID: 38274274
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.
Choi HW; Kim JH; Chung MK; Hong YJ; Jang HS; Seo BJ; Jung TH; Kim JS; Chung HM; Byun SJ; Han SG; Seo HG; Do JT
Stem Cells Dev; 2015 Jun; 24(11):1366-73. PubMed ID: 25590788
[TBL] [Abstract][Full Text] [Related]
12. Dual-specificity Tyrosine Phosphorylation-regulated Kinase Inhibitor ID-8 Promotes Human Somatic Cell Reprogramming by Activating PDK4 Expression.
Xu J; Fang S; Wang N; Li B; Huang Y; Fan Q; Shi J; Liu H; Shao Z
Stem Cell Rev Rep; 2022 Aug; 18(6):2074-2087. PubMed ID: 35080746
[TBL] [Abstract][Full Text] [Related]
13. Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promoters.
Chen H; Zuo Q; Wang Y; Song J; Yang H; Zhang Y; Li B
BMC Biotechnol; 2017 Feb; 17(1):11. PubMed ID: 28193206
[TBL] [Abstract][Full Text] [Related]
14. An improved method for the derivation of high quality iPSCs in the absence of c-Myc.
Habib O; Habib G; Choi HW; Hong KS; Do JT; Moon SH; Chung HM
Exp Cell Res; 2013 Dec; 319(20):3190-200. PubMed ID: 24095950
[TBL] [Abstract][Full Text] [Related]
15. OCT4, SOX2 and NANOG co-regulate glycolysis and participate in somatic induced reprogramming.
Ding Y; Yuan X; Zou Y; Gao J; Xu X; Sun H; Zuo Q; Zhang Y; Li B
Cytotechnology; 2022 Jun; 74(3):371-383. PubMed ID: 35733702
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.
van den Hurk M; Kenis G; Bardy C; van den Hove DL; Gage FH; Steinbusch HW; Rutten BP
Epigenomics; 2016 Aug; 8(8):1131-49. PubMed ID: 27419933
[TBL] [Abstract][Full Text] [Related]
17. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
18. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic and Transcriptional Analyses Reveal Atmospheric Oxygen During Human Induced Pluripotent Stem Cell Generation Impairs Metabolic Reprogramming.
Spyrou J; Gardner DK; Harvey AJ
Stem Cells; 2019 Aug; 37(8):1042-1056. PubMed ID: 31042329
[TBL] [Abstract][Full Text] [Related]
20. An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.
Borgohain MP; Haridhasapavalan KK; Dey C; Adhikari P; Thummer RP
Stem Cell Rev Rep; 2019 Apr; 15(2):286-313. PubMed ID: 30417242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
